RK

Ranjay Kumar

Active Director Director DIN 10793722
DIN 10793722 First appointment Sep 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Ranjay Kumar

Data last updated:

Ranjay Kumar is a Director at Soskid Pharma Private Limited (since 2024). The company operates in Healthcare. Soskid Pharma Private Limited reported revenue of ₹23.1 Lakh (FY 2025).

DIN 10793722
Primary Designation Director
Industry Healthcare
First Appointment 30 Sep 2024
Oldest Company Age 2 yrs
Largest company Soskid Pharma Private Limited · ₹23.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Soskid Pharma Private Limited U47721HR2024PTC125218
Director30 Sep 20242024₹23.1 Lakh (FY 2025)Active

Board colleagues of Ranjay Kumar

NameDINCompanyDesignation
Roshan Kumar Rai05207677Soskid Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Soskid Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjay Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjay Kumar

Ranjay Kumar currently holds 1 directorship: Soskid Pharma Private Limited (Director, since 30 Sep 2024, revenue ₹23.1 Lakh (FY 2025)).

Ranjay Kumar was first appointed on 30 Sep 2024 as Director at Soskid Pharma Private Limited.

The current boards of Ranjay Kumar's companies include Roshan Kumar Rai (Soskid Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available